https://www.zacks.com/stock/news/2222118/wix-com-wix-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2222118
Feb 06, 2024 - In the most recent trading session, Wix.com (WIX) closed at $129.21, indicating a +0.99% shift from the previous trading day.
zc:7380062899060545494
0
https://www.zacks.com/stock/news/2222095/dave-buster-s-play-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2222095
Feb 06, 2024 - Dave & Buster's (PLAY) closed the most recent trading day at $54.35, moving +1.44% from the previous trading session.
zc:6077192516009363115
0
https://www.zacks.com/stock/news/2222096/nexstar-broadcasting-group-nxst-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2222096
Feb 06, 2024 - In the closing of the recent trading day, Nexstar Broadcasting Group (NXST) stood at $172.92, denoting a +0.79% change from the preceding trading day.
zc:251010666684759063
0
https://www.zacks.com/stock/news/2221950/compared-to-estimates-lilly-lly-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2221950
Feb 06, 2024 - While the top- and bottom-line numbers for Lilly (LLY) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-160638097740742065
0
https://www.zacks.com/stock/news/2221899/tradeweb-tw-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2221899
Feb 06, 2024 - Although the revenue and EPS for Tradeweb (TW) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-7615026035325588842
0
https://seekingalpha.com/article/4667794-zymeworks-key-readout-for-zanidatamab-this-year-and-adc-pipeline-expansion?source=feed_tag_editors_picks
Feb 06, 2024 - Zymeworks Stock:Topline results from phase 3 trial of zanidatamab in GEA Patients are expected in late 2024. The author estimates a ~70% success rate.
0
sa:5420438310492583343
0
https://www.zacks.com/stock/news/2221874/compared-to-estimates-kkr-co-inc-kkr-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2221874
Feb 06, 2024 - Although the revenue and EPS for KKR & Co. Inc. (KKR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:8004923398729370486
0
https://www.zacks.com/stock/news/2221875/cummins-cmi-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2221875
Feb 06, 2024 - While the top- and bottom-line numbers for Cummins (CMI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-5325504077480614190
0
https://www.rttnews.com/3422039/australia-central-bank-holds-key-rate-at-4-35.aspx?type=alleco
Feb 05, 2024 - The Reserve Bank of Australia decided to keep its benchmark rate unchanged, as widely expected, on Tuesday.
0
rttnews:-6198803444791126470
0
https://www.zacks.com/stock/news/2221422/coherent-cohr-reports-q2-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2221422
Feb 05, 2024 - Although the revenue and EPS for Coherent (COHR) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:7669770251571295079
0